Spain Cell and Gene Therapy Manufacturing QC Market Size & Outlook, 2025-2028
Spain Cell and Gene Therapy Manufacturing QC Market Size
According to Straits Research analysis, the Spain Cell and Gene Therapy Manufacturing QC Market was valued at USD 60.34 Million in 2024 and is projected to reach USD 151.89 Million by 2028, expanding at a CAGR of 26% during the forecast period. Primary applications driving the demand are from industries such as pharmaceuticals, biotech, and healthcare sector, with an increasing need for the development of innovative and effective therapies. Notable market drivers are found within the chemical and energy sectors, where these therapies can offer potential solutions for disease treatment and preventive care. Emerging trends include advanced technological innovations and a growing inclination towards sustainability and low-carbon production in pharmaceutical manufacturing. Spain is strategically positioning itself as an innovation hub, tapping on its export potential in the global cell and gene therapy market.
Source: Straits Research Analysis Company Publications, Primary Interviews.
Spain Cell and Gene Therapy Manufacturing QC Market Highlights
- By 2024, Cell Therapy represented the largest share of the Therapy Type market size.
- Gene Therapy is expected to remain the key growth driver within Therapy Type, registering the fastest CAGR during the forecast period.
- In 2024, Spain accounted for 2.7% of the global cell and gene therapy manufacturing qc market size.
- By 2028, United States is expected to lead the global cell and gene therapy manufacturing qc market in terms of market size.
- Within Europe, Germany is projected to dominate the regional cell and gene therapy manufacturing qc market size by 2028.
- France is identified as the fastest-growing market in Europe, anticipated to reach USD 45534 Million by 2028.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2028 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2028 |
| Market Size In 2024 | USD 60.34 Million |
| Market Size In 2028 | USD 151.89 Million |
| Largest segment | Cell Therapy |
| Fastest segment | Gene Therapy |
| Units | Revenue in USD Million |
| CAGR | 26% (2025-2028) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Spain Cell and Gene Therapy Manufacturing QC Market Share By Therapy Type
Segmentation Covered
| Segments | Sub Segments |
|---|---|
| Therapy Type |
|
| Cell Therapy |
|
| CAR-T |
|
| Gene Therapy |
|
| Viral |
|
| Scale |
|
| Mode |
|
| Workflow |
|
| Process |
|
| End User |
|
| Pharmaceutical Companies |
|
| Biopharmaceutical / Biotechnological Companies |
|
| Contract Manufacturing Organizations |
|
| Technology Type |
|
Spain Cell and Gene Therapy Manufacturing QC Market By Therapy Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Spain Cell and Gene Therapy Manufacturing QC Market By Cell Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Spain Cell and Gene Therapy Manufacturing QC Market By CAR-T 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Spain Cell and Gene Therapy Manufacturing QC Market By Gene Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Spain Cell and Gene Therapy Manufacturing QC Market By Viral 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Spain Cell and Gene Therapy Manufacturing QC Market By Scale 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Spain Cell and Gene Therapy Manufacturing QC Market By Mode 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Spain Cell and Gene Therapy Manufacturing QC Market By Workflow 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Spain Cell and Gene Therapy Manufacturing QC Market By Process 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Spain Cell and Gene Therapy Manufacturing QC Market By End User 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Spain Cell and Gene Therapy Manufacturing QC Market By Pharmaceutical Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Spain Cell and Gene Therapy Manufacturing QC Market By Biopharmaceutical / Biotechnological Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Spain Cell and Gene Therapy Manufacturing QC Market By Contract Manufacturing Organizations 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Spain Cell and Gene Therapy Manufacturing QC Market By Technology Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
